Advaxis Inc (ADXS) - Financial and Strategic SWOT Analysis Review

  • ID: 1292019
  • SWOT Analysis
  • 52 pages
  • GlobalData
  • Advaxis Inc
1 of 5

FEATURED COMPANIES

  • Aduro BioTech Inc
  • Agenus Inc
  • Celldex Therapeutics Inc
  • ISA Pharmaceuticals BV
  • MedImmune LLC
  • Neon Therapeutics Inc
  • MORE
Advaxis Inc (ADXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Advaxis Inc (Advaxis) is a biotechnology company that focuses on the discovery, development and commercialization of multiple cancer immunotherapies. The company develops immunotherapies based on its proprietary Lm Technology that uses bioengineered live attenuated Listeria monocytogenes (Lm) bacteria to stimulate cancer-fighting T cells directed against a cancer antigen, and lessen factors that protect the tumor microenvironment from immunologic attack and contribute to tumor growth. Under the Lm Technology platform, the company has four immunotherapy candidates in development, Axalimogene filolisbac (AXAL) in Human Papilloma Virus (HPV)-associated cancers; Neoantigen Therapy (ADXS-NEO); ADXS-PSA in prostate cancer; and ADXS-HER2 in HER2-expressing solid tumors. Advaxis is headquartered in Princeton, New Jersey, the US.

Advaxis Inc Key Recent Developments

Dec 20, 2017: Advaxis Reports Fiscal Year 2017 Financial Results and Provides a Business Update
Dec 12, 2017: How Immunotherapy of Cancer May Create Novel Clinical Utilities for HLA Typing
Nov 01, 2017: Advaxis to Receive $4.5 Million through the New Jersey Economic Development Authority NOL Program
Sep 11, 2017: Advaxis Reports Business Update and Third Quarter 2017 Results
Jul 07, 2017: Princeton biotech Advaxis CEO and President resigns

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Aduro BioTech Inc
  • Agenus Inc
  • Celldex Therapeutics Inc
  • ISA Pharmaceuticals BV
  • MedImmune LLC
  • Neon Therapeutics Inc
  • MORE
Section 1 - About the Company
  • Advaxis Inc - Key Facts
  • Advaxis Inc - Key Employees
  • Advaxis Inc - Key Employee Biographies
  • Advaxis Inc - Major Products and Services
  • Advaxis Inc - History
  • Advaxis Inc - Company Statement
  • Advaxis Inc - Locations And Subsidiaries
  • Head Office
Section 2 - Company Analysis
  • Company Overview
  • Advaxis Inc - Business Description
  • Advaxis Inc - Corporate Strategy
  • Advaxis Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Advaxis Inc - Strengths
  • Advaxis Inc - Weaknesses
  • Advaxis Inc - Opportunities
  • Advaxis Inc - Threats
  • Advaxis Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Advaxis Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Dec 20, 2017: Advaxis Reports Fiscal Year 2017 Financial Results and Provides a Business Update
  • Dec 12, 2017: How Immunotherapy of Cancer May Create Novel Clinical Utilities for HLA Typing
  • Nov 01, 2017: Advaxis to Receive $4.5 Million through the New Jersey Economic Development Authority NOL Program
  • Sep 11, 2017: Advaxis Reports Business Update and Third Quarter 2017 Results
  • Jul 06, 2017: Advaxis Announces Change in Leadership
  • Jun 13, 2017: Advaxis Details Registrational Trials, EU Regulatory and Commercial Plans at Annual Investor & Analyst Day
  • Jun 01, 2017: Synthetic Genomics Launches cGMP Suite for Pharmaceutical Quality Manufacturing of Synthetic DNA for Advaxis' Clinical Trials
  • Apr 19, 2017: Advaxis Appoints Anthony Lombardo as Chief Business Officer
  • Mar 07, 2017: Advaxis Appoints Al Blunt, M.D., as its Vice President of Medical
  • Jan 09, 2017: Advaxis Provides 2017 Business Outlook
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Advaxis Inc, Key Facts
  • Advaxis Inc, Key Employees
  • Advaxis Inc, Key Employee Biographies
  • Advaxis Inc, Major Products and Services
  • Advaxis Inc, History
  • Advaxis Inc, Key Competitors
  • Advaxis Inc, Ratios based on current share price
  • Advaxis Inc, Annual Ratios
  • Advaxis Inc, Annual Ratios
  • Advaxis Inc, Interim Ratios
  • Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Advaxis Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Advaxis Inc, Performance Chart (2013 - 2017)
  • Advaxis Inc, Ratio Charts
  • Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Advaxis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Aduro BioTech Inc
  • Agenus Inc
  • Cascadian Therapeutics Inc
  • Celldex Therapeutics Inc
  • Inovio Pharmaceuticals Inc
  • ISA Pharmaceuticals BV
  • MedImmune LLC
  • Neon Therapeutics Inc
  • Oncolytics Biotech Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll